Loading…

Thermo Fisher Scientific has extended its all-cash tender offer to purchase all outstanding shares of Patheon N.V. to coordinate with regulatory approvals in the EU and Brazil. The offer now expires August 28, 2017.
“Based on progress to date, Thermo Fisher now expects to complete the transaction around the end of the third quarter of 2017.”biospace.com
Summarized from public sources; check the original articles before acting on it.